Joseph Adrian Tyndall,MD,MPH, FACEP,professor ofemergencymedicineand surgery, executive vice president forhealthservices,and dean forMorehouse School of Medicine, will become the nextHal B. Jenson, MDDean, president and CEOof 91̽ University Homer Stryker M.D. School of Medicine (91̽) on March 1, 2026.
“This opportunity to serve as91̽’sdean, president,and CEO comes atan important pointin my career. My years in academic medicine have deepened my understanding of what it takes to guide an institution with clarity, purpose, and a commitment to excellence,” Dr. Tyndall said. “91̽hasdemonstratedwhat is possible when innovation, health equity, education, and community partnership work together in service of a larger mission, and that foundation speaks for itself. As we look ahead, I am committed to building on this momentum and strengthening91̽’spresence and influence locally and nationally by deepening partnerships across disciplines and institutions, expanding our research enterprise, and preparing the next generation of physicians and scientists to lead with integrity, compassion, and purpose.”
Dr.Tyndallis a nationally recognized academicleader, educator, and physicianexecutivewhose career spans more than two decades ofemergency medicine clinical practice,transformative contributions to medical education, health system leadership, and emergency medicine. He has been the executive vice president for health services, and dean for Morehouse School of Medicine since July 2021and servedas a member of theGrady Memorial Hospital Corporation Board of Directors. Prior to that he was at the University of Florida(UF)from 2006 through June 2021serving as thechair of the Department of Emergency Medicine for more than a decade before being appointed interim dean of the UF College of Medicine where he led thecollege through the challenges posed by the COVID-19 pandemic. During his time at Florida, he also served asassociate vice president for strategic and academic affairsfor UF Health, asa memberof the UF Health Shands Hospital System Board of Directors,and chairedthe Florida Clinical Practice Association,Florida Group Practice Association, and the UF HealthProton Therapy Institute Board of Directors.Healso previouslyheld academic appointments at State University of New YorkHealth ScienceCenter at Brooklyn School of Medicine,Weill Medical College of Cornell University, and New York University School of Medicine.
“We are excited to welcome Dr. Tyndall as the next Hal B. Jenson, MD Dean,president, and CEO. The91̽Board of Directors is confident his experience and vision will be invaluable in shaping91̽'snext chapter,”saidRussKavalhuna, chair of the medical school Board of Directors and president of 91̽ University.
Dr.Tyndall’sselectionfollows a national search that began in February 2025 tofill the dean position that was vacated in February 2024 with the departure of the medical school’s second dean Paula M.Termuhlen, MD. Since then, Robert G.Sawyer, MD, the senior associate dean for research, has been serving as the interim dean. Hal B. Jenson, MD, MBA,91̽’sfounding dean, retired in May 2021 after leading the medical school during its first 10 years.
The comprehensive and competitive search process was led by Bill Manns,amember of the91̽Board of Directors and president of Bronson Healthcare Group,who servedas the chair of the14-member dean search committee.In October, three candidates came to91̽for two-day visits that included interviews with more than 50 stakeholders, a presentation by each candidate to the medical school community, and a reception to meet some of91̽’scommunity partners.
“As chair of the dean search committee, I am proud to welcome Dr. Tyndall as91̽’snew dean, president, and CEO. This appointmentrepresentsour mutual commitment to medical excellence and preparing the next generation of caregivers for our communities. Dr. Tyndall brings extensive experience in academic medicine and leadership, along with proven dedication to health equity and innovation—qualities that will advance our collective missions,”Manns said.
Dr.Tyndallearned an ExecutiveMasters of Public Health(MPH) in Health Services Management and Policy from Columbia University Mailman School of Public Health. Heis a graduate ofthe University of Maryland School of Medicineand completed his emergency medicinetraining at the University ofMaryland Medical Systems where he served as chief resident.At the age of16,hestarted his undergraduate studies at George Washington University graduating with a Bachelor of Science (BS) inchemistryand a minor in music.
He is a Fellow ofthe AmericanCollege of Emergency Physicians and a Diplomate of the American Board of Emergency Medicine. His research portfolio includes leadership and co-investigatorrolesinnumerousNational Institutes of Health(NIH)-and DepartmentofDefense(DOD)-funded clinical trials, particularly in traumatic brain injury, emergency department operations, and health disparitiesas well as arts in health projects supported by the National Endowment of the Arts. He has authored or edited over100peer-reviewed publications, book chapters, and abstracts includinghiscontributionsas an editor for theRosen’s Emergency Medicinestandard reference textbook. Dr. Tyndall has been honored with the Daniel S. Blumenthal Award for Public Health, the Health Equity Leadership Award from the Association of Black Cardiologists,induction intothe Gold HumanismHonor Societyand the Alpha Omega Alpha HonorMedical Society,the Nash Carter Award from the Atlanta Medical Associationas well asnumerous community service awards and academic teaching honors. He has served oncorporate andnational boards and committees including the AAMC Council of Deansadministrative board. He is the past president ofthe Society for Academic Emergency Medicine Foundation, andpast president of the Florida College of Emergency Physicians.He is a frequent invitedkeynotespeaker andhaslectured extensivelybothnationallyand internationallyon topicsincludinghealth equity, medical education, emergency care innovation, and leadership.Most recently, he joined the inaugural working group of theNeuroArtsAcademic Network (NAN), a global coalition advancing the science of arts and aesthetics in health. Launched as part of theNeuroArtsBlueprint initiative, a strategic partnership between the Johns Hopkins University School of Medicine’s International Arts + Mind Lab and Aspen Institute’s Health, Medicine and Society Program, NAN brings together leading universities to shape the emerging field ofNeuroArtsthrough interdisciplinary research, education, and policy innovation.